Partelli, Stefano
Università Vita-Salute San Raffaele,
Italy
2025 Rank: 145095
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 694 out of 141119 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145095 | 123527 |
| Total Cites | 1007 | 1226 |
| H-index | 12 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 183 | 227 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 193 | 237 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 715 | 795 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.54 |
| Self-Citation Percentage |
17.86%
|
|
Partelli, Stefano
Università Vita-Salute San Raffaele,
Italy
2024 Rank: 138384
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 728 out of 132828 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138384 | 112609 |
| Total Cites | 942 | 1147 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 191 | 228 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 196 | 233 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 660 | 754 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.52 |
| Self-Citation Percentage |
17.87%
|
|
Partelli, Stefano
Università Vita-Salute San Raffaele,
Italy
2023 Rank: 108378
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 590 out of 125272 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108378 | 96114 |
| Total Cites | 1037 | 1252 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 218 | 280 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 225 | 288 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 726 | 807 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.55 |
| Self-Citation Percentage |
17.17%
|
|
Partelli, Stefano
IRCCS Ospedale San Raffaele,
Italy
2022 Rank: 125873
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 756 out of 117502 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125873 | 104714 |
| Total Cites | 840 | 1032 |
| H-index | 12 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 187 | 228 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 187 | 229 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 613 | 694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.49 |
| Self-Citation Percentage |
18.60%
|
|
Partelli, Stefano
Università Vita-Salute San Raffaele,
Italy
2021 Rank: 135942
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 840 out of 113113 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 135942 | 112798 |
| Total Cites | 1139 | 1430 |
| H-index | 16 | 18 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 244 | 323 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 245 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 861 | 976 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.47 |
| Self-Citation Percentage |
20.35%
|
|
Partelli, Stefano
Università Vita-Salute San Raffaele,
Italy
2020 Rank: 138028
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 812 out of 80940 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138028 | 123049 |
| Total Cites | 820 | 1017 |
| H-index | 14 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 163 | 216 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 164 | 217 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 610 | 683 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.49 |
| Self-Citation Percentage |
19.37%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.